Research with EASEE®

Our Studies

The EASEE® system has been tested for safety and efficacy in adult patients with focal epilepsy in several European study centers. For two of the clinical studies that began in 2019 and 2020, we expect to receive further long-term results soon. Results and data from these clinical studies will be published.

pre-clinical and clinical studies with EASEE®

20162018201920212023EASEEAnimalEASEEIIEASEElbPre-clinical phaseClinical phaseLine extensionPIMIDES IEASEE4YOUAssessment of interictal activityAssessment of biocompatibilityAssessment of performance and safetyAssessment of responsive neurostimulationAssessment of clinical outcome in kids 12-17y
Study for Children & Adolescents

In 2023, the Precisis team, in collaboration with five pediatric neurology centers in Germany and Austria, initiated a clinical study for children and adolescents. The EASEE4YOU study includes patients with focal epilepsy between the ages of 12 and 17.

Studies for Adults

The EASEE® System is suitable for individuals with focal epilepsy for whom medications are no longer effective or not sufficient. Since September 2022, the EASEE® System has been on the market and is prescribed by neurologists/epileptologists.

Navigate to the Epilepsy Centers
Registration for our Newsletter
News about epilepsy for healthcare professionals directly to inbox
Thank you for your interest in our newsletter
We sent you an email to verify your address. Please open the email and click the link to receive our newsletter
We look forward to keeping you informed at regular intervals
Yes, I'm interested in EASEE® and would like to receive information about it via email. I can withdraw my consent at any time with effect for the future.
We use cookies and other technologies on our website. Some of them are essential, while others help us to improve this website and your experience with it. For more information about how we use your data, please see our privacy policy.